RadNet to acquire iCAD for $103m.

RadNet, a diagnostic imaging services and digital health solutions provider, agreed to acquire iCAD, a clinically proven AI-powered breast health solutions provider, for $103m. "iCAD’s ProFound Breast Health Suite and RadNet’s DeepHealth AI-powered breast screening solutions, together, have the power to materially expand and improve patient diagnosis and outcomes on a global basis through further enabling accuracy and early-detection. With over 1.5k healthcare provider locations, facilitating over 8m annual mammograms in 50 countries, iCAD’s installed base and strong sales, engineering and marketing capabilities will provide us with immediate broad and valuable customer relationships and commercialization capabilities that can accelerate our existing DeepHealth objectives. This business combination is expected to accelerate our global leadership and commitment to AI-powered breast cancer screening, and positions us to further advance population health," Howard Berger, RadNet President and CEO.